Expression data from sorafenib-resistant HCC cells, xenograft model and the corresponding counterparts.

To better identify the key gene involved in sorafenib-resistant HCC cells and uncover potential targets for HCC therapy, the microarray analysis was used to screen the differentially expressed genes in sorafenib-resistant HCC cells, xenograft model and the corresponding counterparts. Parental or Sorafenib-resistant HCC cell lines and HCC xenografts were for RNA extraction and hybridization on Affymetrix microarrays.